Literature DB >> 11477814

[Yishen huanshuai recipe retard progression of chronic renal failure].

D Yin1, X Dai, X Rao.   

Abstract

OBJECTIVE: To investigate the effect of Yishen Huanshuai recipe (YSHSR) on the progression of chronic renal failure (CRF).
METHODS: Forty-six patients with CRF were divided into two groups: group A (self-controlled group, n = 18), whose treatment was subdivided into two stages. During the first stage, the patients treated with low protein diet and controlling blood pressure, while in the second stage, YSHSR was given. Group B(n = 28), whose treatment plan was similar with that of group A in second stage. The rate of progression of CRF was estimated by slope of the creatinine reciporcal (dl/mg) with time (month).
RESULTS: Mean slope of the creatinine reciprocal with time from the group A during the first stage was -0.0104 +/- 0.0021, while during the second stage, it was -0.0034 +/- 0.0018. There was significant difference between them (P < 0.05). Mean slope from the group B was -0.0047 +/- 0.0020. There was also significant difference between that from the group B and that from the group A during the first stage (P < 0.05).
CONCLUSIONS: Low protein and controlling blood pressure plus YSHSR therapy could markedly retard the rate of progression of CRF.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 11477814

Source DB:  PubMed          Journal:  Zhongguo Zhong Xi Yi Jie He Za Zhi        ISSN: 1003-5370


  3 in total

1.  Effects of Huanshuai Recipe Oral Liquid on restructuring glomerular microvasculature and expression of vascular endothelial growth factor in subtotal nephrectomized rats.

Authors:  Shen Li; Xiang-rong Rao; Jin-ye Song; Li-qiang Meng; Lei Qu; Xiao-mei Li
Journal:  Chin J Integr Med       Date:  2010-08-08       Impact factor: 1.978

2.  Efficacy and safety of the Fu-Zheng-Qu-Zhuo method on retarding the progress of chronic kidney disease (stage 3-4): a systematic review and meta-analysis.

Authors:  Shi-Yi Liu; Po Huang; Ning Zhang
Journal:  Ann Transl Med       Date:  2019-03

3.  Beneficial effects of Fu-Zheng-Qu-Zhuo oral liquid combined with standard integrated therapy in patients with chronic kidney disease (stage 3-4): A randomized placebo-controlled clinical trial.

Authors:  Shen Li; Xiang-Rong Rao; Xi-Wen Dai; Kun Pei; Lee Wang; Bao-Min Huo; Xiu-Juan Wang; Ling-Xin Kong; Nan-Nan Zhang; Feng-Mei Lian
Journal:  Medicine (Baltimore)       Date:  2017-07       Impact factor: 1.889

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.